about
A pyruvate-proton symport and an H+-ATPase regulate the intracellular pH of Trypanosoma brucei at different stages of its life cycleTargeting pathogen metabolism without collateral damage to the hostDepletion of UDP-Glucose and UDP-Galactose Using a Degron System Leads to Growth Cessation of Leishmania majorThe structure-function relationship of functionally distinct but structurally similar hexose transporters from Trypanosoma congolense.The suppression of galactose metabolism in procylic form Trypanosoma brucei causes cessation of cell growth and alters procyclin glycoprotein structure and copy number.Leishmania UDP-sugar pyrophosphorylase: the missing link in galactose salvage?Immunobiology of African trypanosomes: need of alternative interventionsComputer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness.Deletion of UDP-glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania majorGalactose metabolism is essential for the African sleeping sickness parasite Trypanosoma bruceiDrug uptake via nutrient transporters in Trypanosoma brucei.On the evolution of hexose transporters in kinetoplastid Protozoans [corrected].The effect of tunicamycin on the glucose uptake, growth, and cellular adhesion in the protozoan parasite Crithidia fasciculata.Volume-sensitive anion channels mediate osmosensitive glutathione release from rat thymocytes.Nutrient transport and pathogenesis in selected parasitic protozoa.Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa.Niche metabolism in parasitic protozoa.Galactose starvation in a bloodstream form Trypanosoma brucei UDP-glucose 4'-epimerase conditional null mutant.PolyA-specific ribonuclease (PARN-1) function in stage-specific mRNA turnover in Trypanosoma brucei.Independent analysis of the flagellum surface and matrix proteomes provides insight into flagellum signaling in mammalian-infectious Trypanosoma brucei.Contribution of glucose transport to the control of the glycolytic flux in Trypanosoma brucei.Sugar nucleotide pools of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major.The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sicknessIdentification, expression and characterisation of a Babesia bovis hexose transporter.Phenotypic characterization of a glucose transporter null mutant in Leishmania mexicanaTrypanosoma brucei UDP-galactose-4'-epimerase in ternary complex with NAD+ and the substrate analogue UDP-4-deoxy-4-fluoro-alpha-D-galactose.Cloning and characterization of the phosphoglucomutase of Trypanosoma cruzi and functional complementation of a Saccharomyces cerevisiae PGM null mutant.The adipocyte as an important target cell for Trypanosoma cruzi infection.Leishmania plasma membrane Mg2+-ATPase is a H+/K+-antiporter involved in glucose symport. Studies with sealed ghosts and vesicles of opposite polarity.A domino effect in drug action: from metabolic assault towards parasite differentiation.Characterization of D-glucose transport in Trypanosoma rangeli
P2860
Q28343896-EFE5DF9A-EBE4-46A5-8BDD-143C4A216B42Q28468608-6867617C-EAA3-498A-B485-1DC77F598429Q28550611-79E9FAD1-E41D-4A6F-A2EF-B1995E3BCBF0Q30886713-277FDE0A-60F9-4E90-9120-0D9C897BD0EBQ31153696-386B69E2-D6CA-4968-A9EA-C776E4466570Q33569844-6D73EFC9-D6B8-4BF3-A3BF-6EB5E467B070Q33680317-FF1B4115-06E6-46CC-98CE-46563E7BF1E0Q33954211-90ACC8A5-56AB-4ACB-8E92-81F36E56E257Q33979086-3DE984CA-9297-4ACE-8CAA-CB2F66EB92B1Q34027098-44BE2C6F-7589-42A8-9FC0-78EEE899EE53Q34071727-75C725B1-E762-44DE-B98D-D36A24DB47D1Q34261772-A21A3C35-60F5-40F4-B8BC-AFEBFEF5E7E4Q34422766-949BB874-B266-47F5-9379-B0CA78D29C28Q34576857-36D403DD-CED6-47BC-9126-8C6FB462BEFBQ35080823-8414B80A-BF18-4E8F-8BBB-8110671B2FEAQ35102950-66BF4ED3-FE4D-470F-8762-2AC5E79D7DD5Q35113597-AEF5238A-ED67-4884-9886-4BE47087902FQ35216711-9B7D75E8-B31D-4EE1-9577-63A465471649Q35271258-027FCE7D-26DC-440A-83EC-1D8C89D339E9Q35497694-61F3FBC7-1D17-4A33-B491-94273DB0F501Q35615506-EEA42E2D-80E4-4BDE-9218-C500ABA73B3DQ35947133-D031FEE3-BCA4-4C85-A245-5B5C163496CDQ36103511-56ED6D3B-34B8-46D2-BED6-BB75F01F03A7Q37208091-2A7EBF19-04BB-4E63-872D-F39D184BE863Q39694165-E1B005A1-D719-41DA-ADD4-3F73C0E46B54Q42259106-48E863BB-1EB2-4531-AF85-942BEE32EF02Q42663071-163B681A-65C9-4445-9F66-B5818B492864Q42815679-B3D29722-A8F1-470A-BEB4-3833F3E6E23AQ43510353-044E713B-7339-4735-9571-20D21E6F6741Q52713114-4E3C6F76-8B0C-4236-A964-66FE80399FB9Q58869348-76E07F07-6A70-4F1E-8A95-B377811FE7BB
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Kinetoplastid glucose transporters.
@en
type
label
Kinetoplastid glucose transporters.
@en
prefLabel
Kinetoplastid glucose transporters.
@en
P2093
P2860
P356
P1433
P1476
Kinetoplastid glucose transporters
@en
P2093
P2860
P304
P356
10.1042/BJ3250569
P407
P478
325 ( Pt 3)
P577
1997-08-01T00:00:00Z